Why the study?
Are plasma endothelin-1 levels elevated in patients with primary aldosteronism compared to healthy subjects?
Are plasma endothelin-1 levels elevated in patients with primary aldosteronism compared to healthy subjects?
Circulating endothelin-1 levels are not elevated in primary aldosteronism and do not appear to be involved in its associated hypertension.
Plasma ET-1 not elevated in primary aldosteronism; leaves open its role in associated hypertension pending prospective data.
This study evaluated the assessment of plasma endothelin-1 (ET-1) levels in primary aldosteronism and its correlation with other vasoactive hormones such as renin, aldosterone, catecholamines, arginine-vasopressin, and atrial natriuretic peptide. Plasma ET-1 was measured in 12 patients with primary aldosteronism (five adenomas and seven primary hyperplasia) and in 15 normal subjects. No significant differences were found in plasma ET-1 between controls and hypertensive patients both in adenoma and primary adrenal hyperplasia (8.8 + 1.6 pg/mL v 6.2 + 1.4 pg/mL v 6.5 + 1.0 pg/mL, P = NS, respectively). Further, no significant correlations were found among ET-1 and vasoactive hormones. In conclusion, these findings show that there are no differences in ET-1 levels between primary aldosteronism patients and healthy subjects. Circulating ET-1 is not involved in the hypertension in primary aldosteronism.
No takes yet. Share an insight, caveat, or question.
Veglio et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: